ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• Autoimmune diseases, including rheumatoid arthritis (RA), are linked to elevated reactive oxygen species (ROS).
• The specific molecular targets of ROS in autoimmunity remain largely undefined.
• Regulatory T cells (Tregs) play a crucial role in maintaining immune tolerance.

Purpose of the Study:

• To elucidate the role of ROS in Treg instability during autoimmune disease.
• To identify the molecular mechanisms by which ROS affect Treg function.
• To explore the potential of targeting ROS pathways for therapeutic intervention in RA.

Main Methods:

• Utilized collagen-induced arthritis (CIA) mouse model for RA.
• Administered antioxidants to assess their impact on inflammation and immune responses.
• Analyzed Treg frequency, SOCS3 expression, PTEN oxidation, and Akt/mTOR/STAT3 signaling pathways.
• Investigated the role of NADPH oxidase 2 (Nox2) in ROS production within Tregs.

Main Results:

• Antioxidant treatment significantly reduced joint inflammation, autoantibody production, and effector T cell responses in CIA mice.
• Treg frequency was diminished in CIA mice but restored by antioxidant therapy.
• Upregulated SOCS3 in Tregs from RA patients and CIA mice was linked to ROS-dependent PTEN oxidation and subsequent signaling.
• NADPH oxidase 2 (Nox2) was identified as a key source of ROS, contributing to Treg instability and decreased Treg frequency.

Conclusions:

• ROS-dependent disruption of Treg homeostasis is a key mechanism in the development and progression of autoimmune diseases.
• Targeting Nox2-derived ROS may represent a promising therapeutic strategy for RA and other autoimmune conditions.
• Understanding ROS-mediated Treg instability offers new insights into immune dysregulation in autoimmunity.